Skip to main content
. 2013 Jan 11;8(1):e53083. doi: 10.1371/journal.pone.0053083

Table 7. Potential causative variants and mutations identified in the blinded clinical samples.

Sample Gene Mutations/variants detected by NGS (blinded) NGS coverage Mutant allele % by NGS Associated CMD sub-type
CMD-1 COL6A3 IVS14-8_-29_delTGTTTCAGGGTATTCCTGGAGAAGACGGC, (het) 87 16 UCMD
CMD-2 None Detected - - -
CMD-3 COL6A2 c.1402C>T; p.R468X, (het) 108 51 UCMD
CMD-4 COL6A3 c.53C>A; p.A18X, (homo) 111 94 UCMD
CMD-5 None Detected - - -
CMD-6 COL6A1 IVS21-2A>G, (het) UCMD
CMD-7 COL6A1 IVS14+1G>A, (het) 19 68 UCMD
CMD-14 COL6A2 Whole Gene Deletion - - UCMD
CMD-15 None Detected - - -
CMD-16 None Detected - - -
CMD-17 None Detected - - -
CMD-18 None Detected - - -
CMD-19 COL6A2 IVS24-9G>A, (het) 14 21 UCMD
CMD-20 LAMA2 LAMA2 c.652_653_delTT (het);c.2230C>T, p.R744X (het) 6894 4440 MDC1A
CMD-21 None Detected - - -
CMD-22 None Detected - - -
CMD-23 None Detected - - -
CMD-24 LAMA2 c.1580G>A; p.C527Y, (homo) 487 94 MDC1A
CMD-25 LAMA2 LAMA2 c.4048C>T; p.R1350X, (het)c.1580G>A; p.C527Y, (het) 96319 4550 MDC1A
CMD-26 None Detected - - -